Business Context and Reporting Period
This Form 8-K Current Report was filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on September 7, 2016, regarding events occurring on September 2, 2016. The filing details the completion of a private placement financing transaction and a related debt conversion.
Key Financial Metrics
- Gross Proceeds: Approximately $4.25 million raised from the sale of 851,000 units.
- Transaction Costs: Placement agent fees of $196,494 were deducted from gross proceeds.
- Debt Conversion: $1.75 million of principal balance from 12% Second-Priority Secured Non-Convertible Promissory Notes Due 2019 was automatically converted into 350,000 units.
- Warrant Issuance: Investors received warrants to purchase 0.90 shares per unit; placement agents received warrants for approximately 29,680 shares.
Material Changes
The primary material change is the capitalization structure resulting from the financing. The company issued 851,000 units (common stock plus warrants) to new investors and 350,000 units to existing note holders via debt conversion. Additionally, the exercise price for 13,125 shares underlying existing 2019 Warrants was reduced to $5.50 to align with the new financing terms.
Outlook, Risks, and Contingencies
- Registration Rights: The company is obligated to file a registration statement with the SEC by October 2, 2016, to cover the resale of shares issued in this transaction.
- Liquidated Damages: Failure to file the registration statement by the deadline or have it declared effective by November 16, 2016 (or December 31, 2016 if reviewed by the SEC) will trigger liquidated damages payable to investors.
- Warrant Terms: Warrants are exercisable until September 2, 2021, at an exercise price of $5.50 per share, with a cashless exercise feature.
Investor Verification Checklist
- Verify the exact net proceeds after all offering expenses beyond the disclosed placement agent fees.
- Confirm the total number of shares outstanding post-closing, including the impact of the 350,000 units issued via debt conversion.
- Review the full text of the Registration Rights Agreement to understand the specific calculation of liquidated damages.
- Check the status of the 12% Second-Priority Secured Non-Convertible Promissory Notes to determine the remaining principal balance after the $1.75 million conversion.